Cancer and the Immune System: The History and Background of Immunotherapy

This article will outline the link between the immune system and cancer, and provide a historical timeline of immunotherapy developmental milestones. Published data and peer reviewed publications/manuscripts, and textbook chapters. Science has provided a greater understanding of the interactions bet...

Celý popis

Uložené v:
Podrobná bibliografia
Vydané v:Seminars in oncology nursing Ročník 35; číslo 5; s. 150923
Hlavní autori: Abbott, Maura, Ustoyev, Yelena
Médium: Journal Article
Jazyk:English
Vydavateľské údaje: United States Elsevier Inc 01.10.2019
Predmet:
Adaptive immunity
Cancer immunotherapy
History
Humans
Immune System - physiology
Immunologic Factors - therapeutic use
Immunotherapy - methods
Immunotherapy history
Innate immunity
Neoplasms - immunology
Neoplasms - therapy
Oncology Nursing - methods
Innate immunity
Adaptive immunity
History
Cancer immunotherapy
Immunotherapy history
ISSN:0749-2081, 1878-3449, 1878-3449
On-line prístup:Získať plný text
Tagy: Pridať tag
Žiadne tagy, Buďte prvý, kto otaguje tento záznam!
Popis
Shrnutí:This article will outline the link between the immune system and cancer, and provide a historical timeline of immunotherapy developmental milestones. Published data and peer reviewed publications/manuscripts, and textbook chapters. Science has provided a greater understanding of the interactions between cancer and the human immune system. As this knowledge has grown, there has been significant progress in the development of clinically effective cancer immunotherapies. Nurses’ knowledge of the different types of immunity and the interaction of cancer cells with the immune system provides foundational knowledge for understanding cancer immunotherapy. Familiarity with the history of cancer immunotherapy will allow nurses to better comprehend why immunotherapy is now a pillar of cancer treatment that continues to develop. This knowledge will translate to better understanding and provision of care for patients receiving immunotherapy for the treatment of cancer.
Bibliografia:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
ObjectType-Review-3
content type line 23
ISSN:0749-2081
1878-3449
1878-3449
DOI:10.1016/j.soncn.2019.08.002